Medpace Holdings, Inc. to Present at Credit Suisse Healthcare Conference
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Medpace (MEDP) PT Raised to $38 at Jefferies; Reiterates Hold
November 1, 2017 8:31 AM EDTJefferies raised its price target on Medpace (NASDAQ: MEDP) to $38.00 (from $34.00) while maintaining a Hold rating following the company's 3Q earnings report. 3Q revenue benefited by ~$1.75M from delayed revenue recognition for work completed in 1H17 but for which the client needed to raise funds.... More
